Sophia Delicou: A Shift Toward Function-Centered Care for Patients with Hemoglobinopathies
Sophia Delicou, Head of Thalassemia and Sickle Cell Unit, Head of the Expertise Center of Hemoglobin Diseases and Their Complications at Hippokrateio General Hospital, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Mediterranean Journal of Hematology and Infectious Diseases, adding:
“New Publication Announcement!
I’m pleased to share our latest publication in the Mediterranean Journal of Hematology and Infectious Diseases.
Our work explores the emerging challenge of aging in patients with thalassemia and sickle cell disease, proposing a gerontological framework to better understand and manage the growing population of adults living beyond midlife with these conditions.
Key insights:
- Hemoglobinopathies are increasingly becoming lifelong chronic conditions, with more patients reaching their 50s and beyond
- There is a shift from acute, disease-centered care to managing multimorbidity and functional decline
- Clinical priorities should include frailty, cognition, quality of life, and patient-centered outcomes
- Multidisciplinary and integrated care models are essential for optimal long-term management
This work highlights the need to rethink traditional care models and align them with the realities of aging with complex chronic diseases.
Grateful to collaborate with such a dedicated multidisciplinary team.”
Title: Aging with thalassemia and sickle cell disease: A gerontological model of accelerated multimorbidity and function-centered care beyond midlife
Authors: Sophia Delicou, Ioannis Ilias, Athanasia Kapota, Elena Papatheodorou, Maria Moraki, Aikaterini Xydaki, Alexandra Mika, Panagiota Giannou, Irene Kouroukli, Theodoros Aforozis, Myrto Palkopoulou, Christos Savvidis, Iliana Mani, Constantina Aggeli, John Koskinas

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering